Clinical Thyroidology^® for the Public

Volume 19

Clinical Thyroidology^® for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association^®.

In this issue Volume 19 Issue 9, the studies ask the following questions:

• Can active surveillance work for large cancers?
• Could my toxic nodule be cancer?
• Which cancer risk assessment method is the best?
• Should I take extra thyroid hormone for my thyroid cancer?
• Will I need calcium pills after my thyroidectomy?
• Can hypothyroidism cause liver disease?

In this issue Volume 19 Issue 8, the studies ask the following questions:

• Do TSH levels in older adults change with age?
• Can I stop my levothyroxine?
• Can my cancer treatment cause my Graves’ disease to relapse?
• Can TRAb levels predict long-term relapse risk after antithyroid drug therapy for Graves’ disease?
• Can RFA cure my Graves’ disease?
• Can my thyroid nodule be destroyed by only 1 RFA treatment?

Clinical Thyroidology^® for the Public Past Issues

2014 – 2026

2011 – 2013

2008 – 2010

Editor
Alan P. Farwell, MD, FACE
Boston Medical Center
Boston University Chobanian & Avedisian
School of Medicine, Section of Endocrinology,
Diabetes, Nutrition and Weight Management
72 East Concord St., C3, Boston, MA 02118

Editorial Board
Gary Bloom, New York, NY
Maria Brito, MD, Dallas, TX
Susana Ebner, MD, Boston, MA
Alina Gavrila, MD, MMSC, Boston, MA
Poorani Goundan, MD, San Francisco
Sun Lee, MD, Boston, MA
Joanna Miragaya, MD, Atlanta, GA
Jason D. Prescott, MD PhD, New York, NY
Marjorie Safran, MD, Worcester, MA
Phillip Segal, MD, Toronto, ON, Canada
Vibhavasu Sharma, MD, Albany, NY
Pinar Smith, MD, Chicago, IL
Ebru Sulanc, MD , Detroit, MI
Whitney Woodmansee, MD, Gainesville, FL

Follow @thyroidfriends